Recall: D-0073-2027
Class II - Potentially Harmful
Class IIClassification
2026-10-15Initiated
OngoingStatus
The Ritedose CorporationFirm
Product
Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC
Reason
Failed Impurities/Degradation Specification
Distribution
Nationwide within the U.S
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.